期刊文献+

尿毒清颗粒结合非布司他治疗高尿酸血症的效果 被引量:1

Effect of Niaoduqing Granules combined with Febuxostat in the treatment of hyperuricemia
下载PDF
导出
摘要 目的探讨尿毒清颗粒结合非布司他治疗高尿酸血症(HUA)的临床效果。方法选取2018年6月~2019年9月于我院就诊的40例HUA患者作为研究对象,按照随机数字表法将其分为对照组和观察组,每组各20例。对照组患者采用非布司他治疗,研究组患者采用非布司他结合尿毒清颗粒治疗。观察两组患者的临床疗效、实验室相关指标、生活质量、不良反应发生情况。结果观察组患者的治疗总有效率(95.00%)高于对照组(75.00%),差异有统计学意义(P<0.05)。治疗后,观察组患者的血肌酐、血尿酸、随机尿清蛋白值、胱抑素C浓度低于对照组,差异有统计学意义(P<0.05)。观察组患者治疗后的生活质量(SF-12)量表各项评分高于对照组,差异有统计学意义(P<0.05)。两组患者的不良反应总发生率比较,差异无统计学意义(P>0.05)。结论尿毒清颗粒结合非布司他治疗HUA的临床效果显著,安全性良好,可有效控制因该病而改变的各项指标,改善患者肾功能,提高生活质量。 Objective To explore the clinical effect of Niaoduqing Granules combined with Febuxostat in the treatment of hyperuricemia(HUA).Methods Forty HUA patients who treated in our hospital from June 2018 to September 2019 were selected as the research objects,and were divided into control group and observation group according to the random number table method,20 cases in each group.The control group was treated with Febuxostat,and the observation group was treated with Niaoduqing Granules combined with Febuxostat.The clinical efficacy,laboratory-related indicators,quality of life,and adverse reactions of the two groups were observed.Results The total effective rate of the observation group(95.00%)was higher than that of the control group(75.00%),the difference was statistically significant(P<0.05).After treatment,serum creatinine,serumuricacid,random urinary albumin,cystatin C concentration in the observation group were lower than those in the control group,the differences were statistically significant(P<0.05).The scores of the quality of life(SF-12)scale after treatment in the observation group were higher than those in the control group,the differences were statistically significant(P<0.05).The total incidence of adverse reactions between the two groups was not statistically significant(P>0.05).Conclusions Niaoduqing Granules combined with Febuxostat has significant clinical efficacy and good safety.It can effectively control various indicators that change due to the disease and Improve quality of life.
作者 曾碧珊 ZENG Bi-shan(Department of Nephrology,Guangdong Provincial Second Traditional Chinese Medicine Hospital,Guangzhou510000,China)
出处 《中国当代医药》 2020年第23期29-31,35,共4页 China Modern Medicine
基金 广东省中医药局科研项目(20171026)。
关键词 尿毒清颗粒 非布司他 高尿酸血症 血尿酸 Niaoduqing Granules Febuxostat Hyperuricemia Serumuric acid
  • 相关文献

参考文献15

二级参考文献125

  • 1无症状高尿酸血症合并心血管疾病诊治建议中国专家共识[J].中国医学前沿杂志(电子版),2010,2(3):49-55. 被引量:76
  • 2李屹,何立群.针刺结合活血扶正中药干预大量蛋白尿致早中期慢性肾衰的研究[J].上海中医药杂志,2006,40(2):26-28. 被引量:19
  • 3Yokoi K,Adachi H,Hirai Y,et al.Plasma endothelin-1 level is a predictor of 10-year mortality in a general population:the Tanushimaru study[J].Circ J,2012,76(12):2779-2784.
  • 4Cappola TP,Kass DA,Nelson GS,et al.Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy[J].Circulation,2001,104(20):2407-2411.
  • 5Sui X,Church TS,Meriwether RA,et al.Uric acid and the development of metabolic syndrome in women and men[J].Metabolism,2008,57(6):845-852.
  • 6George J,Carr E,Davies J,et al.High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid[J].Circulation,2006,114(23):2508-2516.
  • 7Schumacher HR,Becker MA,Wortmann RL,et al.Effects of febuostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout:a 28-week,phase Ⅲ,randomized,double-blind,parallel-group trial[J].Arthritis Rheum,2008,59(11):1540-1548.
  • 8Van Beneden R,Gurne O,Selvais PL,et al.Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure:a 7-year follow-up study[J].Card Fail,2004,10(6):490-495.
  • 9Rudijanto A.The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis[J].Acta Med Indones,2007,39(2):86-93.
  • 10朱君,余俊文.高尿酸血症和痛风的流行病学及其危险因素的研究进展[J].现代生物医学进展,2008,8(1):191-195. 被引量:86

共引文献271

同被引文献23

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部